newsfilter
← Latest News
GlobeNewswire·

Ultragenyx Releases 2025 Impact Report Emphasizing Commitment to Rare Disease Patients, Innovation, and Global Impact

NOVATO, Calif., July 08, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) released its 2025 Impact Report, detailing the company's work on behalf of patients and families living with rare and